You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Opioid Withdrawal Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,

Recruiting
  • Neonatal Opioid Withdrawal Syndrome
  • Neonatal Abstinence Syndrome
  • microRNA-146a level
  • +2 more
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 30, 2023

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal

Not yet recruiting
  • Delirium in the Intensive Care Unit
  • Administration of methadone instead of fentanyl patch
  • Kfar Saba, Israel
    Meir medical center Kfar Saba
Jan 15, 2023

Neonatal Opiate Withdrawal Syndrome Trial in United States (Symptom-based Dosing Approach, Scheduled Opioid Taper Approach)

Not yet recruiting
  • Neonatal Opiate Withdrawal Syndrome
  • Symptom-based Dosing Approach
  • Scheduled Opioid Taper Approach
  • Birmingham, Alabama
  • +8 more
Jul 27, 2023

Neonatal Opioid Withdrawal Syndrome Trial in Las Vegas, Philadelphia (CHF6563, Morphine, CHF6563 matched )

Terminated
  • Neonatal Opioid Withdrawal Syndrome
  • Las Vegas, Nevada
  • +1 more
Mar 11, 2022

Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome Trial in Indianapolis (Morphine

Completed
Has Results
  • Neonatal Abstinence Syndrome
  • +2 more
  • Morphine PRN
  • Morphine scheduled
  • Indianapolis, Indiana
    Indiana University Health Methodist Hospital
Sep 9, 2022

Outcomes of Babies With Opioid Exposure Study

Recruiting
  • Neonatal Opioid Withdrawal Syndrome
    • Birmingham, Alabama
    • +5 more
    Jan 31, 2023

    Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

    Not yet recruiting
    • Opiate Withdrawal Syndrome
    • Opioid Use
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Treatment Research Center
    Aug 18, 2023

    Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)

    Not yet recruiting
    • Opioid Withdrawal (Disorder)
    • Standard of Care with Lofexidine
    • Standard of Care without Lofexidine
    • (no location specified)
    Sep 14, 2023

    Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

    Not yet recruiting
    • Opioid Use Disorder
    • Opioid Withdrawal
    • BXCL501 (180 micrograms)
    • +3 more
    • (no location specified)
    Jan 24, 2023

    Opioid Use Disorder, Opioid Withdrawal, Opioid Craving Trial in Baltimore (Buspirone, Lofexidine, Placebo)

    Not yet recruiting
    • Opioid Use Disorder
    • +3 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit
    Aug 19, 2022

    Neonatal Opioid Withdrawal Syndrome Trial in United States (Morphine, Methadone)

    Recruiting
    • Neonatal Opioid Withdrawal Syndrome
    • Birmingham, Alabama
    • +26 more
    Jun 22, 2022

    Neonatal Abstinence Syndrome Trial in Charleston (Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System)

    Completed
    Has Results
    • Neonatal Abstinence Syndrome
    • Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
    • Charleston, South Carolina
      Medical University of South Carolina
    Dec 7, 2022

    Opioid Withdrawal, Opioid Craving, Opioid Use Disorder Trial in Baltimore (Epidiolex 100 mg/mL Oral Solution, Cherry Syrup Oral

    Completed
    • Opioid Withdrawal
    • +2 more
    • Epidiolex 100 mg/mL Oral Solution
    • Cherry Syrup Oral Solution
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 1, 2022

    Chronic Pain, Drug Dependence of Morphine Type, Symptom, Withdrawal Trial (Probenecid)

    Not yet recruiting
    • Chronic Pain
    • +2 more
    • (no location specified)
    May 20, 2022

    Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)

    Completed
    Has Results
    • Opioid Dependence
    • Acute Opioid Withdrawal Syndrome
    • Lofexidine HCl
    • +2 more
    • Clovis, California
    • +17 more
    Mar 11, 2022

    Withdrawal Symptoms, Opioid Use Disorder, Opioid Use Trial in Atlanta (Transcutaneous Cervical Vagal Nerve Stimulation, Sham

    Not yet recruiting
    • Withdrawal Symptoms
    • +2 more
    • Transcutaneous Cervical Vagal Nerve Stimulation
    • +2 more
    • Atlanta, Georgia
    • +6 more
    Apr 14, 2023

    Opiate Withdrawal Syndrome Trial in Zagazig (Venlafaxine, Lofexidine)

    Completed
    • Opiate Withdrawal Syndrome
    • Zagazig, Sharkia, Egypt
      Faculty of medicine
    Oct 5, 2022

    Opioid Withdrawal, Opioid Use Disorder, Opioid Craving Trial in Baltimore (Morphine, Naloxone + lofexidine pretreatment,

    Recruiting
    • Opioid Withdrawal
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University Bayview Medical Campus
    Feb 18, 2022

    Iatrogenic Withdrawal Syndrome Trial in Nashville (Acupressure)

    Recruiting
    • Iatrogenic Withdrawal Syndrome
    • Acupressure
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 5, 2022

    Opiate Withdrawal Syndrome Trial in Manchester, London (DMX-1002, Placebo)

    Recruiting
    • Opiate Withdrawal Syndrome
    • Manchester, Greater Mancherster, United Kingdom
    • +1 more
    Jul 29, 2022

    Opioid-Related Disorders, Drug Addiction, Pregnancy Related Trial in United States (Buprenorphine Injection, Buprenorphine

    Recruiting
    • Opioid-Related Disorders
    • +7 more
    • Buprenorphine Injection
    • Buprenorphine Sublingual Product
    • San Francisco, California
    • +12 more
    Feb 10, 2022

    Opioid-Related Disorders, Drug Addiction, Pregnancy Related Trial in United States (Buprenorphine Injection, Buprenorphine

    Recruiting
    • Opioid-Related Disorders
    • +7 more
    • Buprenorphine Injection
    • Buprenorphine Sublingual Product
    • San Francisco, California
    • +12 more
    Feb 10, 2022

    Sleep Disorder, Restless Legs Syndrome, Opioid-use Disorder Trial in Boston, Quincy (Pramipexole, Placebo)

    Not yet recruiting
    • Sleep Disorder
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Aug 31, 2021

    Opioid Withdrawal (Disorder) Trial in United States (Lofexidine, Placebo)

    Suspended
    • Opioid Withdrawal (Disorder)
    • Placentia, California
    • +11 more
    Mar 11, 2022

    Opioid Withdrawal Trial in Baltimore, New York, Philadelphia (Pregabalin 200 MG capsules, Placebo oral tablet, Lofexidine 0.18Mg

    Recruiting
    • Opioid Withdrawal
    • Pregabalin 200 MG capsules
    • +2 more
    • Baltimore, Maryland
    • +2 more
    Jan 26, 2022